Back to News

I&G awarded new Rob Burrow Centre for Motor Neurone Disease

Contractor partners I&G have been successfully appointed by Leeds Teaching Hospitals NHS Trust to build the new Rob Burrow Centre for Motor Neurone Disease (MND) in Leeds; a first of its kind facility in the UK.

Procured through the Procure Partnerships Framework via a two stage call off procedure, the new facility situated at the Seacroft Hospital site will advance healthcare provisions in the region and see all MND services housed under one roof, enhancing accessibility and efficiency.

Rugby league icon Rob Burrow CBE is a patient of the Leeds MND service and has spearheaded the campaign to build a dedicated centre and champion MND awareness following his diagnosis in 2019. The centre is made possible through the fundraising efforts of Leeds Hospitals Charity’s Rob Burrow Centre for Motor Neurone Disease appeal, which has now raised over £5.6 million of its £6.8 million target.

The building will be constructed using modern methods of construction, including the utilisation of structurally insulated panels (SIPs) manufactured offsite for swift assembly, allowing a more efficient and environmentally friendly build whilst maintaining stringent quality standards.

The brand-new centre will create a sense of community with peaceful surroundings for patients and their families, and has been designed in close consultation with clinical staff, patients, the wider MND community, as well as the Burrow family.

As well as clinical areas and treatment rooms, the building will include a central space where people can come together, along with reading and quiet spaces, as well as activity, dining and outdoor areas.

Planning has been approved, and the project is due to start on site in the coming weeks.


Faye Dolan, Framework Director at Procure Partnerships Framework, said:

“We’re proud to be working with Leeds Teaching Hospitals NHS Trust once again and trusted with this flagship scheme that will not only improve the facilities for patients and staff, but will create a central hub for innovation, community and treatment of MND. We are delighted that planning has been approved and look forward to working alongside our stakeholders to make Rob’s vision a reality.”


I&G Managing Director, Christopher Carline, added:

“We’re extremely proud to have been appointed through the Procure Partnerships Framework to build this new centre for motor neuron disease; it’s a life-limiting condition that has a profound effect on people diagnosed, as well as their friends and family. We’re delighted to be working alongside Leeds Teaching Hospitals NHS Trust and Leeds Hospitals Charity to deliver a centre that puts patient needs at the heart of the local community.”